NCT02579525View on ClinicalTrials.gov

Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock

NACompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions
Shock; SepticCritical Illness
Interventions
OTHER

Hemodynamical treatment TTP

Based on capillary refilling time, peripheral temperature, mottling, diuresis, MAP safety limit monitoring

OTHER

Hemodynamical treatment MCG

Based on MAP, CVP, urine output monitoring

Trial Locations (2)

00029

Helsinki University Hospital, Helsinki

Unknown

Inselspital, Bern University Hospital, Bern

All Listed Sponsors
collaborator

Insel Gruppe AG, University Hospital Bern

OTHER

lead

Helsinki University Central Hospital

OTHER

NCT02579525 - Targeted Tissue Perfusion Versus Macrocirculatory-guided Standard Care in Patients With Septic Shock | Biotech Hunter | Biotech Hunter